The British Journal of Psychiatry (2007) 191: 82-83. doi: 10.1192/bjp.bp.106.024547
© 2007 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in BJP
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Tungaraza, T.
Right arrow Articles by Poole, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tungaraza, T.
Right arrow Articles by Poole, R.

SHORT REPORTS

Influence of drug company authorship and sponsorship on drug trial outcomes

Tongeji Tungaraza, MRCPsych and Rob Poole, FRCPsych

North East Wales Trust, UK

Correspondence: Dr Rob Poole, Pwll Glas Resource Centre, Pwll Glas Road, Mold, Flintshire CH7 1RA, UK. Tel: +44 (0) 1352 750252; email: eliphaz{at}doctors.org.uk

Declaration of interest T.T. has accepted sponsorship to attend conferences from Janssen-Cilag and Eli Lilly. R.P. has accepted speakers' fees from Lundbeck, Eli Lilly and Pfizer; he has also accepted sponsorship to attend conferences from Wyeth, AstraZeneca and Eli Lilly. No funding was obtained for the present study.

Studies of drug treatments are more likely to report favourable outcomes when they are funded by the pharmaceutical industry. We compared drug trials reported in three major psychiatric journals to investigate these influences. Independent studies were more likely to report negative findings than industry-funded studies. However, the involvement of a drug company employee had a much greater effect on study outcome than financial sponsorship alone.


Related articles in BJP:

Highlights of this issue
Sukhwinder S. Shergill
BJP 2007 191: A2. [Full Text]  



This article has been cited by other articles:


Home page
 NEJMHome page
K. Okike, M. S. Kocher, E. X. Wei, C. T. Mehlman, and M. Bhandari
Accuracy of Conflict-of-Interest Disclosures Reported by Physicians
N. Engl. J. Med., October 8, 2009; 361(15): 1466 - 1474.
[Abstract] [Full Text] [PDF]

Home page
 Tobacco ControlHome page
J E Cohen, M Zeller, T Eissenberg, M Parascandola, R O'Keefe, L Planinac, and S Leischow
Criteria for evaluating tobacco control research funding programs and their application to models that include financial support from the tobacco industry
Tob. Control, June 1, 2009; 18(3): 228 - 234.
[Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
P. Tyrer
From the Editor's desk
The British Journal of Psychiatry, December 1, 2008; 193(6): 524 - 524.
[Full Text] [PDF]

Home page
 J Child NeurolHome page
L. M. Furman
Attention-Deficit Hyperactivity Disorder (ADHD): Does New Research Support Old Concepts?
J Child Neurol, July 1, 2008; 23(7): 775 - 784.
[Abstract] [PDF]

eLetters:

Read all eLetters

A Basic Statistics Perspective on Tungaraza and Poole, 2007
Allan Abbass
BJP Online, 1 Aug 2007 [Full text]